147 related articles for article (PubMed ID: 18286573)
1. Tripeptidyl peptidase II is dispensable for the generation of both proteasome-dependent and proteasome-independent ligands of HLA-B27 and other class I molecules.
Marcilla M; Villasevil EM; de Castro JA
Eur J Immunol; 2008 Mar; 38(3):631-9. PubMed ID: 18286573
[TBL] [Abstract][Full Text] [Related]
2. Role of tripeptidyl peptidase II in MHC class I antigen processing - the end of controversies?
Endert Pv
Eur J Immunol; 2008 Mar; 38(3):609-13. PubMed ID: 18286570
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of serine-peptidase activity enhances the generation of a survivin-derived HLA-A2-presented CTL epitope in colon-carcinoma cells.
Preta G; Marescotti D; Fortini C; Carcoforo P; Castelli C; Masucci M; Gavioli R
Scand J Immunol; 2008 Dec; 68(6):579-88. PubMed ID: 19000094
[TBL] [Abstract][Full Text] [Related]
4. Tripeptidyl peptidase II is the major peptidase needed to trim long antigenic precursors, but is not required for most MHC class I antigen presentation.
York IA; Bhutani N; Zendzian S; Goldberg AL; Rock KL
J Immunol; 2006 Aug; 177(3):1434-43. PubMed ID: 16849449
[TBL] [Abstract][Full Text] [Related]
5. Accumulation of polyubiquitylated proteins in response to Ala-Ala-Phe-chloromethylketone is independent of the inhibition of Tripeptidyl peptidase II.
Villasevil EM; Guil S; López-Ferreras L; Sánchez C; Del Val M; Antón LC
Biochim Biophys Acta; 2010 Sep; 1803(9):1094-105. PubMed ID: 20553980
[TBL] [Abstract][Full Text] [Related]
6. An essential role for tripeptidyl peptidase in the generation of an MHC class I epitope.
Seifert U; Marañón C; Shmueli A; Desoutter JF; Wesoloski L; Janek K; Henklein P; Diescher S; Andrieu M; de la Salle H; Weinschenk T; Schild H; Laderach D; Galy A; Haas G; Kloetzel PM; Reiss Y; Hosmalin A
Nat Immunol; 2003 Apr; 4(4):375-9. PubMed ID: 12598896
[TBL] [Abstract][Full Text] [Related]
7. A giant protease with potential to substitute for some functions of the proteasome.
Geier E; Pfeifer G; Wilm M; Lucchiari-Hartz M; Baumeister W; Eichmann K; Niedermann G
Science; 1999 Feb; 283(5404):978-81. PubMed ID: 9974389
[TBL] [Abstract][Full Text] [Related]
8. No essential role for tripeptidyl peptidase II for the processing of LCMV-derived T cell epitopes.
Basler M; Groettrup M
Eur J Immunol; 2007 Apr; 37(4):896-904. PubMed ID: 17357105
[TBL] [Abstract][Full Text] [Related]
9. Role of tripeptidyl peptidase II in the processing of Listeria monocytogenes-derived MHC class I-presented antigenic peptides.
Grauling-Halama S; Bahr U; Schenk S; Geginat G
Microbes Infect; 2009; 11(8-9):795-802. PubMed ID: 19426827
[TBL] [Abstract][Full Text] [Related]
10. Need for tripeptidyl-peptidase II in major histocompatibility complex class I viral antigen processing when proteasomes are detrimental.
Guil S; Rodríguez-Castro M; Aguilar F; Villasevil EM; Antón LC; Del Val M
J Biol Chem; 2006 Dec; 281(52):39925-34. PubMed ID: 17088258
[TBL] [Abstract][Full Text] [Related]
11. A major role for TPPII in trimming proteasomal degradation products for MHC class I antigen presentation.
Reits E; Neijssen J; Herberts C; Benckhuijsen W; Janssen L; Drijfhout JW; Neefjes J
Immunity; 2004 Apr; 20(4):495-506. PubMed ID: 15084277
[TBL] [Abstract][Full Text] [Related]
12. Generation of major histocompatibility complex class I antigens: functional interplay between proteasomes and TPPII.
Kloetzel PM
Nat Immunol; 2004 Jul; 5(7):661-9. PubMed ID: 15224091
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the role of tripeptidyl peptidase II in MHC class I antigen presentation in vivo.
Kawahara M; York IA; Hearn A; Farfan D; Rock KL
J Immunol; 2009 Nov; 183(10):6069-77. PubMed ID: 19841172
[TBL] [Abstract][Full Text] [Related]
14. Changes in spatio-temporal localization of tripeptidyl peptidase II (TPPII) in murine colon adenocarcinoma cells during aggresome formation: a microscopy study based on a novel fluorescent proteasome inhibitor.
Bialy LP; Kuckelkorn U; Henklein P; Fayet J; Wilczyński GM; Kamiński A; Mlynarczuk-Bialy I
Histol Histopathol; 2019 Apr; 34(4):359-372. PubMed ID: 30226264
[TBL] [Abstract][Full Text] [Related]
15. Role of tripeptidyl peptidase II in MHC class I antigen presentation: Biological characteristics, cellular crosstalk and signaling.
Tan Q; Ma S; Hu J; Chen X; Yu Y; Zang G; Tang Z
Biomed Pharmacother; 2016 Dec; 84():1954-1958. PubMed ID: 27829551
[TBL] [Abstract][Full Text] [Related]
16. Cells adapted to the proteasome inhibitor 4-hydroxy- 5-iodo-3-nitrophenylacetyl-Leu-Leu-leucinal-vinyl sulfone require enzymatically active proteasomes for continued survival.
Princiotta MF; Schubert U; Chen W; Bennink JR; Myung J; Crews CM; Yewdell JW
Proc Natl Acad Sci U S A; 2001 Jan; 98(2):513-8. PubMed ID: 11149939
[TBL] [Abstract][Full Text] [Related]
17. Adenovirus Vector Harboring the HBcAg and Tripeptidyl Peptidase II Genes Induces Potent Cellular Immune Responses In Vivo.
Tan Q; Ma S; Hu J; Chen X; Yu Y; Tang Z; Zang G
Cell Physiol Biochem; 2017; 41(2):423-438. PubMed ID: 28214886
[TBL] [Abstract][Full Text] [Related]
18. Tripeptidyl peptidase II promotes maturation of caspase-1 in Shigella flexneri-induced macrophage apoptosis.
Hilbi H; Puro RJ; Zychlinsky A
Infect Immun; 2000 Oct; 68(10):5502-8. PubMed ID: 10992446
[TBL] [Abstract][Full Text] [Related]
19. Processing of two latent membrane protein 1 MHC class I epitopes requires tripeptidyl peptidase II involvement.
Diekmann J; Adamopoulou E; Beck O; Rauser G; Lurati S; Tenzer S; Einsele H; Rammensee HG; Schild H; Topp MS
J Immunol; 2009 Aug; 183(3):1587-97. PubMed ID: 19587004
[TBL] [Abstract][Full Text] [Related]
20. Effect of cancer cachexia on the activity of tripeptidyl-peptidase II in skeletal muscle.
Chand A; Wyke SM; Tisdale MJ
Cancer Lett; 2005 Feb; 218(2):215-22. PubMed ID: 15670899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]